I initially thought .01-.02 but Regen BioPharma is further in progress than I thought....given it seems to be reaching this target quicker than I thought (despite the 1B O/S that Koos informed SEC) I think I have to re-evaluate the target to .04-.05, with a peak at .10 (placing the market capital at 100M, 20-40M higher than AMBS reached at its peak).
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.